Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Elevance Health jumped 3.1% in the last session, extending its six-day rally. The surge was fueled by investor optimism, a ...

Elevance Health ELV -2.57% + Free Alerts has outperformed the market over the past 15 years by 2.24% on an annualized basis producing an average annual return of 13.22%. Currently, Elevance Health has ...

Dr. Joyce A. O’Shaughnessy, described by her peers as a ‘legend in the space,’ leads breast cancer research and treatment ...

Shares of Elevance Health Inc. ELV shed 2.61% to $411.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 ...

Massive antitrust settlements last year and in 2020 were supposed to end a protracted legal battle for the Blue Cross and ...

Blue Cross Blue Shield was hit with six federal antitrust suits on the day of the deadline for health care provider class ...

Meanwhile, a suit filed against Cigna in California says the insurer denied over 300,000 claims in two months—about 1.2 ...

Republican lawmakers in the U.S. House of Representatives are targeting major reforms for the Medicaid healthcare program as ...

KP, Mental Health Workers Take Step Toward Ending Strike: Officials with Kaiser Permanente have reportedly agreed to mediation in their longstanding negotiation with the National Union of Healthcare ...

Consumer Reports published its study findings related to products used in braids, extensions, and other hairstyles. Other news from the intersection of race and health is on the barriers to care faced ...